BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 18205883)

  • 1. Reproductive counselling, treatment and course of pregnancy in 73 German MS patients.
    Hellwig K; Brune N; Haghikia A; Müller T; Schimrigk S; Schwödiauer V; Gold R
    Acta Neurol Scand; 2008 Jul; 118(1):24-8. PubMed ID: 18205883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glatiramer acetate versus interferon beta-1a for subcutaneous administration: comparison of outcomes among multiple sclerosis patients.
    Castelli-Haley J; Oleen-Burkey M; Lage MJ; Johnson KP
    Adv Ther; 2008 Jul; 25(7):658-73. PubMed ID: 18641926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological characteristics of pregnancy, delivery, and birth outcome in women with multiple sclerosis in Argentina (EMEMAR study).
    Fernández Liguori N; Klajn D; Acion L; Cáceres F; Calle A; Carrá A; Cristiano E; Deri N; Garcea O; Jaureguiberry A; Onaha P; Patrucco L; Riccio P; Rotta Escalante R; Saladino Ml; Sinay V; Tarulla A; Villa A
    Mult Scler; 2009 May; 15(5):555-62. PubMed ID: 19299437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy and multiple sclerosis: the children of PRIMS.
    Vukusic S; Confavreux C
    Clin Neurol Neurosurg; 2006 Mar; 108(3):266-70. PubMed ID: 16413965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple sclerosis and reproductive risks in women.
    Argyriou AA; Makris N
    Reprod Sci; 2008 Oct; 15(8):755-64. PubMed ID: 19017813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple sclerosis: management issues during pregnancy.
    Ferrero S; Pretta S; Ragni N
    Eur J Obstet Gynecol Reprod Biol; 2004 Jul; 115(1):3-9. PubMed ID: 15223156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy and multiple sclerosis.
    Houtchens MK
    Semin Neurol; 2007 Nov; 27(5):434-41. PubMed ID: 17940922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnancy in multiple sclerosis patients treated with immunomodulators prior to or during part of the pregnancy: a descriptive study in the Spanish population.
    De Las Heras V; De Andrés C; Téllez N; Tintoré M;
    Mult Scler; 2007 Sep; 13(8):981-4. PubMed ID: 17623725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practical consultations: multiple sclerosis.
    Wingerchuk DM; Carter JL
    Semin Neurol; 2003 Sep; 23(3):253-64. PubMed ID: 14722821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relapse rate of multiple sclerosis changes during pregnancy: a cohort study.
    Salemi G; Callari G; Gammino M; Battaglieri F; Cammarata E; Cuccia G; D'Amelio M; Lupo I; Ragonese P; Savettieri G
    Acta Neurol Scand; 2004 Jul; 110(1):23-6. PubMed ID: 15180803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer incidence in multiple sclerosis and effects of immunomodulatory treatments.
    Achiron A; Barak Y; Gail M; Mandel M; Pee D; Ayyagari R; Rotstein Z
    Breast Cancer Res Treat; 2005 Feb; 89(3):265-70. PubMed ID: 15754125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Multiple sclerosis and pregnancy. Overview and status of the European multicenter PRIMS study].
    Flachenecker P; Hartung HP
    Nervenarzt; 1995 Feb; 66(2):97-104. PubMed ID: 7715760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple sclerosis, immunomodulators, and pregnancy outcome: a prospective observational study.
    Weber-Schoendorfer C; Schaefer C
    Mult Scler; 2009 Sep; 15(9):1037-42. PubMed ID: 19692433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-beta1b in multiple sclerosis: effect on progression of disability and clinical markers of treatment response.
    Carmona O; Casado V; Moral E; Alonso-Magdalena L; Martínez-Yélamos A; Martínez-Yélamos S; Martín-Ozaeta G; Arbizu T
    Eur Neurol; 2008; 60(6):279-84. PubMed ID: 18824855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Still no evidence on the efficacy of immunomodulatory therapy in reducing functional impairment in multiple sclerosis].
    Vermeulen M
    Ned Tijdschr Geneeskd; 2007 Apr; 151(15):850-1. PubMed ID: 17472114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid hormones in multiple sclerosis.
    El-Etr M; Vukusic S; Gignoux L; Durand-Dubief F; Achiti I; Baulieu EE; Confavreux C
    J Neurol Sci; 2005 Jun; 233(1-2):49-54. PubMed ID: 15878598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First trimester interleukin 8 levels are associated with postpartum relapse in multiple sclerosis.
    Neuteboom RF; Verbraak E; Voerman JS; van Meurs M; Steegers EA; de Groot CJ; Laman JD; Hintzen RQ
    Mult Scler; 2009 Nov; 15(11):1356-8. PubMed ID: 19797262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis.
    Gorman MP; Healy BC; Polgar-Turcsanyi M; Chitnis T
    Arch Neurol; 2009 Jan; 66(1):54-9. PubMed ID: 19139299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy and multiple sclerosis. An Australian perspective.
    Frith JA; McLeod JG
    Clin Exp Neurol; 1987; 24():1-4. PubMed ID: 3268333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Having children after surviving cancer in childhood or adolescence - results of a Berlin survey.
    Reinmuth S; Liebeskind AK; Wickmann L; Bockelbrink A; Keil T; Henze G; Borgmann A
    Klin Padiatr; 2008; 220(3):159-65. PubMed ID: 18478488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.